Merck Stock Is Up 61% in a Year. Is There Room Left to Run?

Key TakeawaysMerck stock is up 61% over the past year to $144 at the Oct 2 close, with the sharpest leg coming Aug 19 on the Phase 3 INTerpath-001 melanoma win. Scotiabank’s Sept 29 target hike to $180 from $155 sits 25% above the close.